These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10234158)

  • 1. Selective proteasome inhibitors: modulators of antigen presentation?
    Groettrup M; Schmidtke G
    Drug Discov Today; 1999 Feb; 4(2):63-71. PubMed ID: 10234158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.
    Sijts A; Zaiss D; Kloetzel PM
    Curr Mol Med; 2001 Dec; 1(6):665-76. PubMed ID: 11899255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen.
    Yang B; Hahn YS; Hahn CS; Braciale TJ
    J Exp Med; 1996 Apr; 183(4):1545-52. PubMed ID: 8666912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolysis and class I major histocompatibility complex antigen presentation.
    York IA; Goldberg AL; Mo XY; Rock KL
    Immunol Rev; 1999 Dec; 172():49-66. PubMed ID: 10631936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: involvement of nonproteasomal cytosolic proteases in antigen processing?
    Vinitsky A; Antón LC; Snyder HL; Orlowski M; Bennink JR; Yewdell JW
    J Immunol; 1997 Jul; 159(2):554-64. PubMed ID: 9218569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class I antigen processing regulated by cytosolic proteolysis-short cuts that alter peptide generation.
    Kessler BM; Glas R; Ploegh HL
    Mol Immunol; 2002 Oct; 39(3-4):171-9. PubMed ID: 12200049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation.
    Momburg F; Ortiz-Navarrete V; Neefjes J; Goulmy E; van de Wal Y; Spits H; Powis SJ; Butcher GW; Howard JC; Walden P
    Nature; 1992 Nov; 360(6400):174-7. PubMed ID: 1299222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using protease inhibitors in antigen presentation assays.
    Basler M; Groettrup M
    Methods Mol Biol; 2013; 960():31-39. PubMed ID: 23329476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI31 is a modulator of proteasome formation and antigen processing.
    Zaiss DM; Standera S; Kloetzel PM; Sijts AJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14344-9. PubMed ID: 12374861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of mass spectrometry to identify antigens from proteasome processing.
    Burlet-Schiltz O; Claverol S; Gairin JE; Monsarrat B
    Methods Enzymol; 2005; 405():264-300. PubMed ID: 16413318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse Norovirus Infection Reduces the Surface Expression of Major Histocompatibility Complex Class I Proteins and Inhibits CD8
    Fritzlar S; Jegaskanda S; Aktepe TE; Prier JE; Holz LE; White PA; Mackenzie JM
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.
    Harding CV; France J; Song R; Farah JM; Chatterjee S; Iqbal M; Siman R
    J Immunol; 1995 Aug; 155(4):1767-75. PubMed ID: 7636233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells.
    Leclerc D; Beauseigle D; Denis J; Morin H; Paré C; Lamarre A; Lapointe R
    J Virol; 2007 Feb; 81(3):1319-26. PubMed ID: 17121795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.
    Sewell AK; Price DA; Teisserenc H; Booth BL; Gileadi U; Flavin FM; Trowsdale J; Phillips RE; Cerundolo V
    J Immunol; 1999 Jun; 162(12):7075-9. PubMed ID: 10358150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
    Buckner FS; Wipke BT; Van Voorhis WC
    Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
    Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
    J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.
    Becker HJ; Kondo E; Shimabukuro-Vornhagen A; Theurich S; von Bergwelt-Baildon MS
    Eur J Haematol; 2016 Aug; 97(2):166-74. PubMed ID: 26561366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Processing of MHC class I presented antigens].
    van Endert P
    Med Sci (Paris); 2006; 22(8-9):727-32. PubMed ID: 16962047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.